Related Experiment Videos
Tolerance of full dose menogaril (NSC 269148) in patients with abnormal hepatic and renal function
B A Conley1, M J Egorin, V Sinibaldi
1Division of Development Therapeutics, University of Maryland Cancer Center, Baltimore.
Investigational New Drugs
|November 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.
NPJ precision oncology·2022
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
[Acute abdomen in renal transplant recipients. Epidemiology and treatment in not referral transplantation centers].
Il Giornale di chirurgia·2011
Parthenolide enhances imatinib activity in gastrointestinal stromal tumor models through stress-associated apoptosis.
Investigational new drugs·2026
First-in-human phase I study of DT-9081, a selective EP4 receptor antagonist, in advanced solid tumors.
Investigational new drugs·2026
Novel EGFR tyrosine kinase inhibitors exhibiting intrinsic fluorescence.
Investigational new drugs·2026
Outcomes of SGLT2 inhibitors after transcatheter mitral valve repair in patients with type 2 diabetes mellitus.
Journal of cardiovascular medicine (Hagerstown, Md.)·2026
A Case Report of Refractory Allergic Bronchopulmonary Aspergillosis: The Art of Selection, Discontinuation and Switching Biologics.
Journal of inflammation research·2026
APRIL-driven BCMA/TACI dual-targeted ligand-drug conjugates for selective and potent therapy of multiple myeloma.
Acta pharmaceutica Sinica. B·2026
Red light-responsive bioorthogonal chemistry enabled on-demand prodrug activation for cancer therapy.
Acta pharmaceutica Sinica. B·2026
Muscle Organoids and Organs-on-Chips: A 15-Year Global Bibliometric Perspective.
Tissue engineering. Part B, Reviews·2026
Allogeneic haematopoietic stem cell transplantation in late-onset metachromatic leukodystrophy.
Brain : a journal of neurology·2026